- Home
- ERAS vs RJET Comparison
ERAS vs RJET Comparison
Compare ERAS & RJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ERAS | RJET |
|---|---|---|
| Founded | 2018 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.7M | 1.0B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ERAS | RJET |
|---|---|---|
| Price | $3.27 | $18.85 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.71 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 20.0K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 93.20 |
| Revenue | N/A | ★ $1,597,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.21 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $1.01 | $17.35 |
| 52 Week High | $3.48 | $21.57 |
Technical Indicators
Market Signals| Indicator | ERAS | RJET |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | N/A |
| Support Level | $3.13 | N/A |
| Resistance Level | $3.48 | N/A |
| Average True Range (ATR) | 0.22 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 66.44 | 0.00 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About RJET Republic Airways Holdings Inc. Common Stock
Republic Airways Holdings Inc operates a fleet of 240+ Embraer 170/175 aircraft and offers scheduled passenger service with daily flights to cities across the U.S., Canada, the Caribbean and Central America.